Literature DB >> 2384670

Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation.

P Zanovello1, V Bronte, A Rosato, P Pizzo, F Di Virgilio.   

Abstract

Extracellular ATP (ATPo) caused dose-dependent lysis of YAC-1 and P-815 mouse tumor cells. This event, assessed by 51Cr release, was accompanied by sustained depolarization of the plasma membrane potential and Ca2+ influx. Plasma membrane depolarization and Ca2+ influx occurred within a few seconds of ATPo addition to both cell types, whereas 51Cr was released without apparent lag in YAC-1 cells and after 2 h in P-815 cells. Furthermore, a rise in [Ca2+]i was required for ATPo-dependent lysis of YAC-1 but not P-815 cells. In P-815 cells, ATPo caused an early and [Ca2+]i-independent DNA fragmentation that occurred at lower nucleotide concentrations than those required to trigger 51Cr release. Instead in YAC-1 cells very low concentrations of ATPo caused early lysis (ED50 for lysis about 200 microM) accompanied by only barely detectable DNA fragmentation. Previous studies disclosed that lymphokine-activated killer cells are fully resistant to the membrane-perturbing effects of ATPo. We show that lymphokine-activated killer cells also do not undergo DNA fragmentation even in the presence of high ATPo concentrations. This study complements previous observations on the lytic effects of ATPo and shows that this nucleotide can also cause DNA fragmentation, one of the earliest target cell alterations observed during CTL-mediated lysis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384670

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Angiostatin binds ATP synthase on the surface of human endothelial cells.

Authors:  T L Moser; M S Stack; I Asplin; J J Enghild; P Højrup; L Everitt; S Hubchak; H W Schnaper; S V Pizzo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  Functional evidence of distinct ATP activation sites at the human P2X(7) receptor.

Authors:  M Klapperstück; C Büttner; G Schmalzing; F Markwardt
Journal:  J Physiol       Date:  2001-07-01       Impact factor: 5.182

3.  Amyloid-beta induces a caspase-mediated cleavage of P2X4 to promote purinotoxicity.

Authors:  R Varma; Y Chai; J Troncoso; J Gu; H Xing; S S Stojilkovic; M P Mattson; N J Haughey
Journal:  Neuromolecular Med       Date:  2009-06-27       Impact factor: 3.843

4.  Enhanced lipid peroxidation by extracellular ATP in PC12 cells.

Authors:  Y Cheng; M Chen; M James-Kracke; P Wixom; A Y Sun
Journal:  Neurochem Res       Date:  1996-01       Impact factor: 3.996

5.  Magnesium-Dependent Ecto-ATP Diphosphohydrolase Activity in Leishmania donovani.

Authors:  Preeti Sinha; Ranjeet Kumar Paswan; Anjali Kumari; Sanjay Kumar; Sanjeeva Bimal; Pradeep Das; Chandra Shekhar Lal
Journal:  Curr Microbiol       Date:  2016-09-02       Impact factor: 2.188

6.  Target cell death triggered by cytotoxic T lymphocytes: a target cell mutant distinguishes passive pore formation and active cell suicide mechanisms.

Authors:  D S Ucker; J D Wilson; L D Hebshi
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

7.  Interleukin 1 is processed and released during apoptosis.

Authors:  K A Hogquist; M A Nett; E R Unanue; D D Chaplin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

8.  P2 receptor-mediated signaling in mast cell biology.

Authors:  Elena Bulanova; Silvia Bulfone-Paus
Journal:  Purinergic Signal       Date:  2009-11-17       Impact factor: 3.765

9.  Characterization of the cytotoxic effect of extracellular ATP in J774 mouse macrophages.

Authors:  M Murgia; P Pizzo; T H Steinberg; F Di Virgilio
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

10.  The roles of ASK family proteins in stress responses and diseases.

Authors:  Kazuki Hattori; Isao Naguro; Christopher Runchel; Hidenori Ichijo
Journal:  Cell Commun Signal       Date:  2009-04-24       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.